共 414 条
[1]
Carey LA(2006)Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492-2502
[2]
Perou CM(2015)Triple-negative breast cancer: new perspectives for targeted therapies OncoTargets Ther 8 177-2767
[3]
Livasy CA(2011)Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies J Clin Invest 121 2750-1887
[4]
Dressler LG(2012)Dissecting the heterogeneity of triple-negative breast cancer J Clin Oncol 30 1879-5540
[5]
Cowan D(2013)Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes Clin Cancer Res 19 5533-1698
[6]
Conway K(2014)Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer Clinical Cancer Research 21 1688-1281
[7]
Karaca G(2008)Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 26 1275-122
[8]
Troester MA(2011)Current treatment options in triple negative breast cancer Breast Dis 32 99-533
[9]
Tse CK(2017)Olaparib for metastatic breast cancer in patients with a germline BRCA mutation N Engl J Med 377 523-763
[10]
Edmiston S(2018)Talazoparib in patients with advanced breast cancer and a germline BRCA mutation N Engl J Med 379 753-2467